Evidence map›Paper›PMID 38082469›Full record

ArticleDiabetes, obesity & metabolism2024

Clinical effectiveness and cost-impact after 2 years of a ketogenic diet and virtual coaching intervention for patients with diabetes.

Kiersten L Strombotne, Jessica Lum, Steven D Pizer, Stuart Figueroa, Austin B Frakt, Paul R Conlin

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kiersten L StrombotneDepartment of Health Law, Policy & Management, Boston University of Public Health, Boston, Massachusetts, USA.ORCID 0000-0002-7457-7211
Jessica LumVA Boston Healthcare System, Boston, Massachusetts, USA.
Steven D PizerDepartment of Health Law, Policy & Management, Boston University of Public Health, Boston, Massachusetts, USA.
Stuart FigueroaDepartment of Health Law, Policy & Management, Boston University of Public Health, Boston, Massachusetts, USA.
Austin B FraktDepartment of Health Law, Policy & Management, Boston University of Public Health, Boston, Massachusetts, USA.
Paul R ConlinVA Boston Healthcare System, Boston, Massachusetts, USA.
Boston University · USHarvard University · USVA Boston Healthcare System · US

Funding

Hemoglobin A1C Variability as a Risk Factor for Diabetes ComplicationsR01DK114098 · NIDDK · HARVARD MEDICAL SCHOOL · PI CONLIN, PAUL R · 2019 to 2022
$2.3M
NIDDK NIH HHS R01 DK114098
6 · The paper itself

Abstract

aimWe previously evaluated the impacts at 5 months of a digitally delivered coaching intervention in which participants are instructed to adhere to a very low carbohydrate, ketogenic diet. With extended follow-up (24 months), we assessed the longer-term effects of this intervention on changes in clinical outcomes, health care utilization and costs associated with outpatient, inpatient and emergency department use in the Veterans Health Administration. MATERIALS AND

methodsWe employed a difference-in-differences model with a waiting list control group to estimate the 24-month change in glycated haemoglobin, body mass index, blood pressure, prescription medication use, health care utilization rates and associated costs. The analysis included 550 people with type 2 diabetes who were overweight or obese and enrolled in the Veterans Health Administration for health care. Data were obtained from electronic health records from 2018 to 2021.

resultsThe virtual coaching and ketogenic diet intervention was associated with significant reductions in body mass index [-1.56 (SE 0.390)] and total monthly diabetes medication usage [-0.35 (SE 0.054)]. No statistically significant differences in glycated haemoglobin, blood pressure, outpatient visits, inpatient visits, or emergency department visits were observed. The intervention was associated with reductions in per-patient, per-month outpatient spending [-USD286.80 (SE 97.175)] and prescription drug costs (-USD105.40 (SE 30.332)].

conclusionsA virtual coaching intervention with a ketogenic diet component offered modest effects on clinical and cost parameters in people with type 2 diabetes and with obesity or overweight. Health care systems should develop methods to assess participant progress and engagement over time if they adopt such interventions, to ensure continued patient engagement and goal achievement.

Indexed as

Diabetes Mellitus, Type 2Diet, KetogenicMentoringGlycated HemoglobinHumansObesityOverweightTreatment OutcomeGlycated Hemoglobindietary interventionhealth economicsreal-world evidencetype 2 diabetes

Identifiers

PMID38082469
PMCPMC10987085
OpenAlexW4389628142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.